Locking this in.HEading toward $2.00
this just my view, sales to flow though soon expecting minimum 15m in sales this upcoming quarter with 20 - 25 the following.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.020 AUD
−13.87 M AUD
1.03 M AUD
1.36 B
About BOTANIX PHARMACEUTICALS LTD
Sector
Industry
CEO
Howie McKibbon
Website
Headquarters
West Perth
Founded
1984
ISIN
AU000000BOT2
FIGI
BBG000BB1YZ8
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.
BOT Journey to $1.00 and beyond. BOT will in the next 6 -+ 12 months reach heights unimagineable only 12 months ago. Strap in, were going for a ride.
what i think probably continue bouncing through the channel until sales hit the quarterly at which point in time it'll just burst through 0.60 and remain above. aimho - dyor
testig out BOT and saving here for recordsjust how i think it could possibly play out... I think it'll stay above 0.19 but lets see
0.28 and beyondUpcoming FDA approval should see BOT finally get to 0.28 and above... Just a very basic channel i am following.
BOT - Wyckoff Accumulation SchematicPotentially accumulating right now, publishing so that I can follow to see what happens on this one! Note that I've charted using Heikin Ashi as it paints a clearer picture on this. I've drawn roughly what you'd expect to see from here if we are in an accumulation range.
Phase A:
The Preliminary
Bullish potential detected for BOTFollowing a few stocks in the ASX of particular interest, BOT represents a potential bullish opportunity should momentum continue and higher highs and higher lows be made past the current position. I'll cover this more in the upcoming weekly video, however as can be seen in the chart, the stock pric
Key point on BOT - where to? Couple of things to unpack here, we're at a Pivotal point right now just holding the .618 Fibonacci retracement level on the recent move.
DOW Theory suggests "The secondary, or intermediate, trend represents corrections in the primary trend and usually lasts three weeks to three months. These inte
Botanix: Dead Cat Bounce?Recent events have caused what was a 'guaranteed' FDA approval price-pump to fall 40+% at their low (so far) with FDA requiring additional 'Patient Instruction update'.
I'm looking for a short term move back to .14-.15 on bullish divergence, bearing in mind there's a much larger hidden bearish div
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of BOT is 0.380 AUD — it hasn't changed in the past 24 hours. Watch BOTANIX PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BOTANIX PHARMACEUTICALS LTD stocks are traded under the ticker BOT.
BOT stock has fallen by −5.00% compared to the previous week, the month change is a −2.56% fall, over the last year BOTANIX PHARMACEUTICALS LTD has showed a 33.33% increase.
We've gathered analysts' opinions on BOTANIX PHARMACEUTICALS LTD future price: according to them, BOT price has a max estimate of 0.80 AUD and a min estimate of 0.60 AUD. Watch BOT chart and read a more detailed BOTANIX PHARMACEUTICALS LTD stock forecast: see what analysts think of BOTANIX PHARMACEUTICALS LTD and suggest that you do with its stocks.
BOT stock is 4.00% volatile and has beta coefficient of 1.45. Track BOTANIX PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is BOTANIX PHARMACEUTICALS LTD there?
Today BOTANIX PHARMACEUTICALS LTD has the market capitalization of 732.73 M, it has decreased by −12.22% over the last week.
Yes, you can track BOTANIX PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
BOTANIX PHARMACEUTICALS LTD is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
BOTANIX PHARMACEUTICALS LTD revenue for the last half-year amounts to 345.67 K AUD, despite the estimated figure of 11.60 M AUD. In the next half-year revenue is expected to reach 30.30 M AUD.
BOT net income for the last half-year is −30.89 M AUD, while the previous report showed −8.40 M AUD of net income which accounts for −267.60% change. Track more BOTANIX PHARMACEUTICALS LTD financial stats to get the full picture.
No, BOT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOTANIX PHARMACEUTICALS LTD EBITDA is −40.75 M AUD, and current EBITDA margin is −1.49 K%. See more stats in BOTANIX PHARMACEUTICALS LTD financial statements.
Like other stocks, BOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOTANIX PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOTANIX PHARMACEUTICALS LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOTANIX PHARMACEUTICALS LTD stock shows the buy signal. See more of BOTANIX PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.